96 related articles for article (PubMed ID: 6693771)
21. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
22. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
Ekdahl KN; Nilsson B
J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
[TBL] [Abstract][Full Text] [Related]
23. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
Norris KA
Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
[TBL] [Abstract][Full Text] [Related]
24. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
Salhany JM; Sloan RL; Cordes KS
Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.
Kirschfink M; Kovacs B; Mottaghy K
Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684
[TBL] [Abstract][Full Text] [Related]
26. Hydrolytic cleavage of an RNA-model phosphodiester catalyzed by a highly negatively charged polyoxomolybdate [Mo7O24]6- cluster.
Absillis G; Cartuyvels E; Van Deun R; Parac-Vogt TN
J Am Chem Soc; 2008 Dec; 130(51):17400-8. PubMed ID: 19053457
[TBL] [Abstract][Full Text] [Related]
27. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
28. Associated complement C3b. Towards an understanding of its intracellular modifications.
Rey-Millet CA; Chesne S; Colomb MG
Mol Immunol; 1993 Jul; 30(10):855-64. PubMed ID: 8341280
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
Leijh PC; van den Barselaar MT; Daha MR; van Furth R
J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
[TBL] [Abstract][Full Text] [Related]
30. Folding of horse cytochrome c in the reduced state.
Bhuyan AK; Udgaonkar JB
J Mol Biol; 2001 Oct; 312(5):1135-60. PubMed ID: 11580255
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of hyaluronan hydrolysis in acidic solution at various pH values.
Tømmeraas K; Melander C
Biomacromolecules; 2008 Jun; 9(6):1535-40. PubMed ID: 18452332
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of pH-sensitive amphotericin B-poly(ethylene glycol) conjugates and study of their controlled release in vitro.
Sedlák M; Pravda M; Staud F; Kubicová L; Týcová K; Ventura K
Bioorg Med Chem; 2007 Jun; 15(12):4069-76. PubMed ID: 17434312
[TBL] [Abstract][Full Text] [Related]
33. The hemopoietic progenitor 32DCl3(G) cells synthesize C3 molecules and acquire C3b acceptor sites upon differentiation or neoplastic transformation.
Di Renzo L; Zicari A; Longo A; Realacci M; Naso G; Pontieri G; Lipari M
J Immunol; 1993 Oct; 151(7):3737-45. PubMed ID: 8376803
[TBL] [Abstract][Full Text] [Related]
34. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
Lambris JD; Ross GD
J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the binding of human C3b to glycoproteins on rabbit and sheep erythrocytes.
Parker CJ; Bernshaw NJ; Wilcox LA
Complement Inflamm; 1990; 7(1):1-17. PubMed ID: 2323183
[TBL] [Abstract][Full Text] [Related]
36. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation.
Sahu A; Pangburn MK
J Biol Chem; 1994 Nov; 269(46):28997-9002. PubMed ID: 7961863
[TBL] [Abstract][Full Text] [Related]
37. 'Inactivated' third component of complement (C3b-like C3; C3i) acquires C5 binding capacity and supports C5 activation upon covalent fixation to a solid surface.
Vogt W; Lühmann B; Hesse D
Complement; 1984; 1(2):87-96. PubMed ID: 6544185
[TBL] [Abstract][Full Text] [Related]
38. The covalent-binding reaction of complement component C3.
Sim RB; Twose TM; Paterson DS; Sim E
Biochem J; 1981 Jan; 193(1):115-27. PubMed ID: 7305916
[TBL] [Abstract][Full Text] [Related]
39. Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups.
Law SK; Minich TM; Levine RP
Biochemistry; 1984 Jul; 23(14):3267-72. PubMed ID: 6432041
[TBL] [Abstract][Full Text] [Related]
40. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
